Literature DB >> 21644899

Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians.

Joshua S Davis1, Allen C Cheng, Mark McMillan, Alex B Humphrey, Dianne P Stephens, Nicholas M Anstey.   

Abstract

OBJECTIVE: To describe the clinical and epidemiological features of sepsis and severe sepsis in the population of the tropical Top End of the Northern Territory of Australia and compare these with published estimates for temperate Australia, the United States and Europe. DESIGN, SETTING AND PARTICIPANTS: Prospective cohort study in the major hospital for tropical NT, a region where 27% of the population are Indigenous. We screened all adult (≥ 15 years) acute hospital admissions over a 12-month period (6 May 2007-5 May 2008) for sepsis by standard criteria, and collected standardised clinical data. MAIN OUTCOME MEASURES: Population-based incidence of community-onset sepsis and severe sepsis requiring intensive care unit (ICU) admission; 28-day mortality rate and microbial epidemiology.
RESULTS: There were 1191 hospital admissions for sepsis in 1090 patients, of which 604 (50.7%) were Indigenous people; the average age was 46.7 years. The age-adjusted annual population-based incidence of sepsis was 11.8 admissions per 1000 (mortality rate, 5.4%), but for Indigenous people it was 40.8 per 1000 (mortality rate, 5.7%). For severe sepsis requiring ICU admission, the incidence was 1.3 per 1000 per year (mortality rate, 21.5%), with an Indigenous rate of 4.7 per 1000 (mortality rate, 19.3%).
CONCLUSIONS: The incidence of sepsis in the tropical NT is substantially higher than that for temperate Australia, the United States and Europe, and these differences are mainly accounted for by the high rates of sepsis in Indigenous people. The findings support strategies to improve housing and access to health services, and reduce comorbidities, alcohol and tobacco use in Indigenous Australians. The burden of sepsis in indigenous populations worldwide requires further study to guide appropriate resourcing of health care and preventive strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21644899

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  17 in total

Review 1.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis.

Authors:  Danny Tsai; Penelope Stewart; Rajendra Goud; Stephen Gourley; Saliya Hewagama; Sushena Krishnaswamy; Steven C Wallis; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 3.  The Assessment of Social Determinants of Health in Postsepsis Mortality and Readmission: A Scoping Review.

Authors:  Ryan S Hilton; Katrina Hauschildt; Milan Shah; Marc Kowalkowski; Stephanie Taylor
Journal:  Crit Care Explor       Date:  2022-07-29

4.  The Applicability of Commonly Used Severity of Illness Scores to Tropical Infections in Australia.

Authors:  Kris Salaveria; Simon Smith; Yu-Hsuan Liu; Richard Bagshaw; Markus Ott; Alexandra Stewart; Matthew Law; Angus Carter; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2021-10-18       Impact factor: 3.707

5.  Antibiotic Therapy in Adults with Malaria (ANTHEM): High Rate of Clinically Significant Bacteremia in Hospitalized Adults Diagnosed with Falciparum Malaria.

Authors:  Ne Myo Aung; Phyo Pyae Nyein; Thu Ya Htut; Zaw Win Htet; Tint Tint Kyi; Nicholas M Anstey; Mar Mar Kyi; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

6.  An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.

Authors:  Christabelle J Darcy; Joshua S Davis; Tonia Woodberry; Yvette R McNeil; Dianne P Stephens; Tsin W Yeo; Nicholas M Anstey
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

7.  Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.

Authors:  Thérèse M Kearns; Richard Speare; Allen C Cheng; James McCarthy; Jonathan R Carapetis; Deborah C Holt; Bart J Currie; Wendy Page; Jennifer Shield; Roslyn Gundjirryirr; Leanne Bundhala; Eddie Mulholland; Mark Chatfield; Ross M Andrews
Journal:  PLoS Negl Trop Dis       Date:  2015-10-30

8.  Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians.

Authors:  Steven Y C Tong; Sebastian J van Hal; Lloyd Einsiedel; Bart J Currie; John D Turnidge
Journal:  BMC Infect Dis       Date:  2012-10-09       Impact factor: 3.090

9.  Non-communicable diseases, infection and survival in a retrospective cohort of Indigenous and non-Indigenous adults in central Australia.

Authors:  Lloyd Einsiedel; Liselle Fernandes; Sheela Joseph; Alex Brown; Richard J Woodman
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692

10.  Long term outcomes following hospital admission for sepsis using relative survival analysis: a prospective cohort study of 1,092 patients with 5 year follow up.

Authors:  Joshua S Davis; Vincent He; Nicholas M Anstey; John R Condon
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.